• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路脱宁A类似物的合成及其对拓扑异构酶I的抑制特性

Synthesis and topoisomerase I inhibitory properties of luotonin A analogues.

作者信息

Cagir Ali, Eisenhauer Brian M, Gao Rong, Thomas Shannon J, Hecht Sidney M

机构信息

Department of Chemistry and Department of Biology, University of Virginia, Charlottesville, VA 22901, USA.

出版信息

Bioorg Med Chem. 2004 Dec 1;12(23):6287-99. doi: 10.1016/j.bmc.2004.08.052.

DOI:10.1016/j.bmc.2004.08.052
PMID:15519171
Abstract

Luotonin A, a naturally occurring pyrroloquinazolinoquinoline alkaloid, has been previously demonstrated to be a topoisomerase I poison. A number of luotonin A derivatives have now been prepared through the condensation of anthranilic acid derivatives and 1,2-dihydropyrrolo[3,4-b]quinoline-3-one in the presence of phosphorus oxychloride. When dichloromethane was used as solvent the reaction proceeded to a single product. In contrast when the reaction was carried out in tetrahydrofuran or in phosphorus oxychloride, an additional isomeric product was obtained. The luotonin A analogues were evaluated for their ability to effect stabilization of the covalent binary complex formed between human topoisomerase I and DNA, and for cytotoxicity toward a yeast strain expressing the human topoisomerase I.

摘要

路托替尼A是一种天然存在的吡咯并喹唑啉喹啉生物碱,此前已被证明是一种拓扑异构酶I毒药。现在通过邻氨基苯甲酸衍生物与1,2-二氢吡咯并[3,4-b]喹啉-3-酮在三氯氧磷存在下缩合制备了多种路托替尼A衍生物。当使用二氯甲烷作为溶剂时,反应生成单一产物。相反,当反应在四氢呋喃或三氯氧磷中进行时,会得到一种额外的异构体产物。对路托替尼A类似物进行了评估,以考察它们对人拓扑异构酶I与DNA形成的共价二元复合物的稳定作用能力,以及对表达人拓扑异构酶I的酵母菌株的细胞毒性。

相似文献

1
Synthesis and topoisomerase I inhibitory properties of luotonin A analogues.路脱宁A类似物的合成及其对拓扑异构酶I的抑制特性
Bioorg Med Chem. 2004 Dec 1;12(23):6287-99. doi: 10.1016/j.bmc.2004.08.052.
2
Luotonin A. A naturally occurring human DNA topoisomerase I poison.路托西汀A。一种天然存在的人类DNA拓扑异构酶I毒药。
J Am Chem Soc. 2003 Nov 12;125(45):13628-9. doi: 10.1021/ja0368857.
3
Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.A环和E环取代的路脱宁A衍生物的合成及其对拓扑异构酶的中毒活性
Bioorg Med Chem. 2007 Jun 15;15(12):4237-46. doi: 10.1016/j.bmc.2007.03.067. Epub 2007 Mar 25.
4
Regioselective quinazolinone-directed ortho lithiation of quinazolinoylquinoline: practical synthesis of naturally occurring human DNA topoisomerase I poison luotonin a and luotonins B and E.喹唑啉酮导向的喹唑啉酰基喹啉区域选择性邻位锂化反应:天然存在的人类DNA拓扑异构酶I抑制剂鲁托宁A以及鲁托宁B和E的实用合成方法
J Org Chem. 2004 Jun 25;69(13):4563-6. doi: 10.1021/jo040153v.
5
Synthesis and biochemical properties of E-ring modified luotonin A derivatives.E环修饰的路托品A衍生物的合成及生化性质
Bioorg Med Chem Lett. 2004 May 3;14(9):2051-4. doi: 10.1016/j.bmcl.2004.02.069.
6
Synthesis and cytotoxic activity of substituted luotonin A derivatives.取代路托品 A 衍生物的合成及细胞毒性活性
Bioorg Med Chem Lett. 2004 Dec 6;14(23):5757-61. doi: 10.1016/j.bmcl.2004.09.039.
7
One-pot synthesis of luotonin A and its analogues.洛托辛 A 及其类似物的一锅合成。
Org Lett. 2011 Mar 4;13(5):920-3. doi: 10.1021/ol1029707. Epub 2011 Jan 26.
8
14-azacamptothecin: a potent water-soluble topoisomerase I poison.14-氮杂喜树碱:一种强效水溶性拓扑异构酶I毒药。
J Am Chem Soc. 2005 Jan 26;127(3):838-9. doi: 10.1021/ja0442769.
9
D-Ring-Modified Analogues of Luotonin A with Reduced Planarity: Design, Synthesis, and Evaluation of Their Topoisomerase Inhibition-Associated Cytotoxicity.D-环修饰的 Luotonin A 类似物,平面性降低:设计、合成及其拓扑异构酶抑制相关细胞毒性的评价。
Biomed Res Int. 2019 Nov 13;2019:2514524. doi: 10.1155/2019/2514524. eCollection 2019.
10
Water-soluble camptothecin derivatives that are intrinsic topoisomerase I poisons.水溶性喜树碱衍生物,它们是内在的拓扑异构酶I毒物。
Org Lett. 2004 Feb 5;6(3):321-4. doi: 10.1021/ol030119n.

引用本文的文献

1
Oxone promoted dehydrogenative Povarov cyclization of -aryl glycine derivatives: an approach towards quinoline fused lactones and lactams.过氧单硫酸盐促进的芳基甘氨酸衍生物的脱氢Povarov环化反应:一种合成喹啉稠合内酯和内酰胺的方法。
RSC Adv. 2019 Sep 25;9(52):30277-30291. doi: 10.1039/c9ra06212b. eCollection 2019 Sep 23.
2
Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation.通过环糊精络合提高天然抗癌拓扑异构酶I抑制剂的稳定性和生物活性。
Pharmaceutics. 2021 Oct 3;13(10):1609. doi: 10.3390/pharmaceutics13101609.
3
Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.
通过一锅偶氮-Nazarov-Friedlander 序列设计和合成 C-芳基角型芦竹素及其拓扑异构酶 I 抑制研究以及 C-芳基玉叶金花素和芦竹素。
Bioorg Med Chem Lett. 2021 Jun 1;41:127998. doi: 10.1016/j.bmcl.2021.127998. Epub 2021 Mar 30.
4
D-Ring-Modified Analogues of Luotonin A with Reduced Planarity: Design, Synthesis, and Evaluation of Their Topoisomerase Inhibition-Associated Cytotoxicity.D-环修饰的 Luotonin A 类似物,平面性降低:设计、合成及其拓扑异构酶抑制相关细胞毒性的评价。
Biomed Res Int. 2019 Nov 13;2019:2514524. doi: 10.1155/2019/2514524. eCollection 2019.
5
Position-Selective Synthesis and Biological Evaluation of Four Isomeric A-Ring Amino Derivatives of the Alkaloid Luotonin A.位置选择性合成和生物碱 Luotonin A 的四个 A-环氨基衍生物的生物评价。
Molecules. 2019 Feb 16;24(4):716. doi: 10.3390/molecules24040716.
6
Biologically active quinoline and quinazoline alkaloids part I.具有生物活性的喹啉和喹唑啉生物碱 第一部分。
Med Res Rev. 2018 May;38(3):775-828. doi: 10.1002/med.21466. Epub 2017 Sep 13.
7
A Facile Oxidative Opening of the C-Ring in Luotonin A and Derivatives.Luotonin A 及其衍生物中环 C 的简便氧化开环。
Molecules. 2017 Sep 12;22(9):1540. doi: 10.3390/molecules22091540.
8
Weinreb amidation as the cornerstone of an improved synthetic route to A-ring-modified derivatives of luotonin A.Weinreb 酰胺化作为改进的 A 环修饰洛洛通 A 衍生物合成路线的基石。
Molecules. 2012 Sep 25;17(10):11363-78. doi: 10.3390/molecules171011363.
9
Recent advances in the studies on luotonins.近年来洛托宁研究的新进展。
Molecules. 2011 Jun 14;16(6):4861-83. doi: 10.3390/molecules16064861.
10
Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors.作为拓扑异构酶I抑制剂的14-取代芳香霉素的设计、合成及生物学评价
J Med Chem. 2008 Aug 14;51(15):4609-19. doi: 10.1021/jm800259e. Epub 2008 Jul 17.